MedTrace Logo

Influence of Dexmedetomidine on the Evoked Potentials During Spine Surgery

NCT00494832 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2012-09-14

No results posted yet for this study

Summary

The purposes of this study are:

1. To evaluate the safety and efficacy of Dexmedetomidine as an adjunct for anesthesia during spine surgery and
2. To investigate the influence of Dexmedetomidine on the evoked potentials.

Conditions

  • Spine Surgery

Interventions

DRUG

Dexmedetomidine

10 minutes loading dose of 0.9 mcg/kg Maintenance dose of 0.6 mcg/kg/hour

DRUG

Normal Saline

10 minutes loading dose of 0.9 mcg/kg Maintenance dose of 0.6 mcg/kg/hour

Sponsors & Collaborators

Principal Investigators

  • Irene Rozet, MD · University of Washington

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2010-05-31
Completion
2010-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00494832 on ClinicalTrials.gov